• 'Drugs from bugs' joint venture cphi-online
    April 08, 2019
    Lonza and Chr. Hansen create a strategic joint venture to become the partner of choice for developing and manufacturing live biotherapeutic products for pharma and biotech customers.
  • Chr. Hansen gets patent for its probiotic strain in S Korea biospectrumasia
    March 05, 2018
    This strain is known worldwide for its gastrointestinal health benefits and has now also been shown to hold immunity support benefits.
  • Chr. Hansen expands strain library pharmaasia
    June 16, 2017
    Research on the human microbiome has exploded in recent years revealing it to be of major importance for human health and disease, creating opportunities for development of next generation probiotics.
PharmaSources Customer Service